Literature DB >> 30989313

Toxicological assessment of magnesium oxide nanoparticles in HT29 intestinal cells.

Anna Mittag1, Thomas Schneider2, Martin Westermann3, Michael Glei2.   

Abstract

Nanoparticles (NPs) are increasingly used in different consumer-related areas, for instance in food packaging or as additives, because of their enormous potential. Magnesium oxide (MgO) is an EU-approved food additive (E number 530). It is commonly used as a drying agent for powdered foods, for colour retention or as a food supplement. There are no consistent results regarding the effects of oral MgO NP uptake. Consequently, the aim of this study was to examine the effects of MgO NPs in the HT29 intestinal cell line. MgO NP concentrations ranged from 0.001 to 100 μg/ml and incubation times were up to 24 h. The cytotoxic and genotoxic potential were investigated. Apoptotic processes and cell cycle changes were analysed by flow cytometry. Finally, oxidative stress was examined. Transmission electron microscopy indicated that there was no cellular uptake. MgO NPs had no cytotoxic or genotoxic effects in HT29 cells and they did not induce apoptotic processes, cell cycle changes or oxidative stress.

Entities:  

Keywords:  Flow cytometry; HT29 cells; Magnesium oxide; Nanoparticles; Nanotoxicology; Oral exposure

Mesh:

Substances:

Year:  2019        PMID: 30989313     DOI: 10.1007/s00204-019-02451-4

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  38 in total

Review 1.  Nanomedicine--prospective therapeutic and diagnostic applications.

Authors:  Dwaine F Emerich
Journal:  Expert Opin Biol Ther       Date:  2005-01       Impact factor: 4.388

Review 2.  Applications and implications of nanotechnologies for the food sector.

Authors:  Qasim Chaudhry; Michael Scotter; James Blackburn; Bryony Ross; Alistair Boxall; Laurence Castle; Robert Aitken; Richard Watkins
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2008-03

Review 3.  Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective.

Authors:  Mélanie Auffan; Jérôme Rose; Jean-Yves Bottero; Gregory V Lowry; Jean-Pierre Jolivet; Mark R Wiesner
Journal:  Nat Nanotechnol       Date:  2009-09-13       Impact factor: 39.213

Review 4.  Toxicology of nanoparticles.

Authors:  Andreas Elsaesser; C Vyvyan Howard
Journal:  Adv Drug Deliv Rev       Date:  2011-09-08       Impact factor: 15.470

Review 5.  Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.

Authors:  Abhijit A Date; Justin Hanes; Laura M Ensign
Journal:  J Control Release       Date:  2016-06-09       Impact factor: 9.776

Review 6.  Consideration of interaction between nanoparticles and food components for the safety assessment of nanoparticles following oral exposure: A review.

Authors:  Yi Cao; Juan Li; Fang Liu; Xiyue Li; Qin Jiang; Shanshan Cheng; Yuxiu Gu
Journal:  Environ Toxicol Pharmacol       Date:  2016-07-30       Impact factor: 4.860

7.  Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles.

Authors:  Min Chen; Anna von Mikecz
Journal:  Exp Cell Res       Date:  2005-01-24       Impact factor: 3.905

8.  Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials.

Authors:  Glen M DeLoid; Joel M Cohen; Georgios Pyrgiotakis; Philip Demokritou
Journal:  Nat Protoc       Date:  2017-01-19       Impact factor: 13.491

9.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells.

Authors:  P V AshaRani; Grace Low Kah Mun; Manoor Prakash Hande; Suresh Valiyaveettil
Journal:  ACS Nano       Date:  2009-02-24       Impact factor: 15.881

Review 10.  Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation.

Authors:  Valeria De Matteis
Journal:  Toxics       Date:  2017-10-17
View more
  1 in total

1.  Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway.

Authors:  Ben Liu; Hui Wang
Journal:  Exp Ther Med       Date:  2022-04-13       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.